2014

Regeneron Announces Upcoming 2013 Investor Conference Presentations

TARRYTOWN, N.Y., April 18, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:

  • Baird's 2013 Growth Stock Conference on Wednesday, May 8, 2013.  The presentation is scheduled for 10:45 a.m. Eastern Time (9:45 a.m. Central Time).

  • Credit Suisse 2013 Antibody Day on Friday, May 10, 2013.  The presentation is scheduled for 7:45 a.m. Eastern Time.

  • Bank of America Merrill Lynch 2013 Healthcare Conference on Tuesday, May 14, 2013.  The presentation is scheduled for 6:40 p.m. Eastern Time (3:40 p.m. Pacific Time).

The presentations may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page.  An archived version of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma and atopic dermatitis.  For additional information about the company, please visit www.regeneron.com.

Contact Information: 


Manisha Narasimhan, Ph.D. 

Peter Dworkin

Investor Relations

Corporate Communications                           

914.847.5126

914.847.7640             

manisha.narasimhan@regeneron.com  

peter.dworkin@regeneron.com

SOURCE Regeneron Pharmaceuticals, Inc.



RELATED LINKS
http://www.regeneron.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.